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Mutations in the chloroquine resistance (CQR) transporter gene of Plasmodium falciparum (Pfcrt; chromo-
some 7) play a key role in CQR, while mutations in the multidrug resistance gene (Pfmdr1; chromosome 5) play
a significant role in the parasite’s resistance to a variety of antimalarials and also modulate CQR. To compare
patterns of genetic variation at Pfcrt and Pfmdr1 loci, we investigated 460 blood samples from P. falciparum-
infected patients from four Asian, three African, and three South American countries, analyzing microsatellite
(MS) loci flanking Pfcrt (five loci [40 kb]) and Pfmdr1 (either two loci [5 kb] or four loci [10 kb]). CQR
Pfmdr1 allele-associated MS haplotypes showed considerably higher genetic diversity and higher levels of
subdivision than CQR Pfcrt allele-associated MS haplotypes in both Asian and African parasite populations.
However, both Pfcrt and Pfmdr1 MS haplotypes showed similar levels of low diversity in South American
parasite populations. Median-joining network analyses showed that the Pfcrt MS haplotypes correlated well
with geography and CQR Pfcrt alleles, whereas there was no distinct Pfmdr1 MS haplotype that correlated with
geography and/or CQR Pfmdr1 alleles. Furthermore, multiple independent origins of CQR Pfmdr1 alleles in
Asia and Africa were inferred. These results suggest that variation at Pfcrt and Pfmdr1 loci in both Asian and
African parasite populations is generated and/or maintained via substantially different mechanisms. Since
Pfmdr1 mutations may be associated with resistance to artemisinin combination therapies that are replacing
CQ, particularly in Africa, it is important to determine if, and how, the genetic characteristics of this locus
change over time.
Chloroquine-resistant (CQR) Plasmodium falciparum para-
sites were first detected in the late 1950s in Southeast Asia
(Thailand-Cambodia border) and South America (Venezuela
and Colombia) (64). Resistant parasites from these locations
are thought to have spread steadily throughout Asia and South
America, arriving in East Africa (Kenya and Tanzania) in the
late 1970s and spreading across the African continent within a
decade (64). Resistance to chloroquine arose on the island of
New Guinea during the 1950s, when Dutch colonial officials
implemented chloroquinized-salt programs on that island, long
before it was detected in the mid-1970s (21, 60). Subsequent
reports suggest that CQR had become widespread in Papua
New Guinea (PNG) by the early 1980s (35).
CQR in P. falciparum is linked to point mutations in the
CQR transporter gene (Pfcrt; chromosome 7) (24, 48). The
Pfcrt K76T mutant allele confers resistance in vitro and is the
most reliable molecular marker for CQR (13, 15, 24). Chloro-
quine-sensitive (CQS) strains from all geographic regions
maintain an invariable wild-type CVMNK (amino acids 72 to
76) allele, while there are a number of predominant CQR-
associated alleles: CVIET (Southeast Asia and Africa),
SagtVMNT (SVMNT1; Asia, South America, and Tanzania),
StctVMNT (SVMNT2; South America), CVMET (Colombia),
and CVMNT (South America and the Philippines) (2, 12–14,
24, 34, 58, 61, 65).
Polymorphisms, including copy number variation and point
mutations, in another transporter gene of the parasite, the
multidrug resistance gene (Pfmdr1; chromosome 5), contribute
to the parasite’s susceptibility to a variety of antimalarial drugs
(41, 46, 47). Point mutations in this gene play a modulatory
role in CQR (25, 26). Two Pfmdr1 mutant alleles occur in
CQR strains from different geographic regions: 86Y_184Y_
1034S_1042N_1246D (predominant in Asia and Africa)
and 86N_184F_1034C_1042D_1246Y (predominant in South
America) (25, 59). Although a number of field studies have
observed a significant nonrandom association between the
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CQR Pfcrt 76T and Pfmdr1 86Y alleles (28), suggesting a joint
contribution of these two genes to the CQR phenotype, the
results of other studies have suggested that additional parasite
genes are likely to be involved (11, 36).
The major aims of the present study were (i) to compare the
number of origins of CQR Pfcrt alleles with those of CQR
Pfmdr1 alleles in different locations and (ii) to determine
whether the distribution of microsatellite (MS) haplotypes as-
sociated with CQR Pfmdr1 alleles represents divergent or con-
vergent evolution when compared with the distribution of MS
haplotypes associated with CQR Pfcrt alleles. We have two
main reasons to pursue these aims. First, there seem to be
marked genetic differences between Pfcrt and Pfmdr1 loci. In
their analysis of MS loci flanking Pfcrt, Wootton et al. (65)
observed reduced allelic diversity and shared chromosomal
segments (100 kb on either side of Pfcrt) in 48 laboratory-
adapted CQR isolates obtained worldwide, suggesting CQ se-
lection-driven “sweeps.” The selective sweeps were also seen in
field studies conducted in Southeast Asia (12, 39) and South
America (61), where the sweep sizes may be determined by the
history and strength of CQ selection pressure and the genetic
structure of parasite populations (39). Based on the MS data,
at least five independent origins of CQR Pfcrt alleles world-
wide have been suggested (12, 65). In contrast, the evolution-
ary dynamics of Pfmdr1 are far less clear. Duraisingh et al. (19)
observed significantly lower levels of variation at an intragenic
MS locus associated with Pfmdr1 N86Y alleles in Gambian
parasites and suggested that a limited number of origins and a
selective sweep might be responsible for this observation. On
the other hand, Nair et al. (37) recently reported multiple
independent origins of Pfmdr1 copy number variation and only
limited reduction in MS allelic diversity within a 170- to 250-kb
region flanking Pfmdr1, suggesting “soft” selective sweeps, in
parasites from the Thailand-Burma border. MS data from
Nair’s study suggest that independent origins of the Pfmdr1
locus occur frequently, as five different haplotype groups show-
ing 15 Pfmdr1 amplification events were observed within single
parasite populations. Thus, the reduced variation at Pfcrt but
high variation at Pfmdr1 indicates that polymorphisms in these
two regions of the P. falciparum genome may be generated
and/or maintained via different mechanisms.
The second reason to pursue these aims is that Pfmdr1
polymorphisms may be associated with resistance to newer
artemisinin combination drugs, and it is therefore important to
understand the evolutionary dynamics of the Pfmdr1 locus
under swiftly changing drug pressures. Elevated Pfmdr1 copy
number has been associated with resistance to artesunate-me-
floquine (4) and artemether-lumefantrine (57) combinations in
Southeast Asia. Recent clinical studies in Africa have impli-
cated the Pfmdr1 86N allele as a potential marker of resistance
to the artemether-lumefantrine combination (16, 30, 49). Also,
a high prevalence of parasites containing a potentially novel
allele, 86Y_1246Y, has been observed in East African patients
after treatment with the artesunate-amodiaquine combination
(40) and with amodiaquine alone (29, 30).
In this study, we analyzed 460 blood samples from P. falcip-
arum-infected patients from diverse regions of Asia (PNG,
Indonesia, Laos, and India), Africa (Kenya, Uganda, and
Ghana), and South America (Brazil, Colombia, and Guyana)
where malaria is endemic for both the Pfcrt and the Pfmdr1
alleles and their flanking MS haplotypes. Our results provide
new insights into the evolutionary dynamics of Pfcrt and
Pfmdr1 loci in the Asian and African parasite populations and
also reveal contrasting genetic features of the Pfmdr1 locus in
the populations from Asia/Africa and South America.
MATERIALS AND METHODS
Blood samples. (i) Asia. In PNG, 143 samples were collected in the areas of
Dreikikir (East Sepik Province; n  36; July to September 1996), the Wosera
(East Sepik Province; n  76; July 1998 to January 1999), and Liksul (Madang
Province; n  31; May to July 2000) (34, 35). In Indonesia, 34 samples were
collected from both symptomatic and asymptomatic patients in Nias Island,
located off the northwestern coast of Sumatra, in August 1998 (27, 53). In Laos,
29 samples were collected from malaria patients in Luang Namtha Province from
October to December 2003 (14, 50). In India, 32 samples were collected from
patients with fever attending malaria clinics in the states of Goa (medium levels
of CQR; n  2), Assam (high levels of CQR; n  18), and Uttar Pradesh (low
levels of CQR; n  12) in 2001 (62).
(ii) Africa. In western Kenya, 39 samples were collected in the villages of
Kabobo (Uasin Gishu district, Rift Valley Province; n  8; August 1996 to March
1997) (31) and Kanyawegi (Kisumu district, Nyanza Province; n  31; November
2000) (32). In Uganda, 30 samples were collected from children aged 7 years or
younger with uncomplicated falciparum malaria in Kampala from August 1998 to
March 1999 (17, 18). In Ghana, 51 samples were collected from children aged 2
years or younger in the Navrongo area of the Kassena-Nankana District (n  25
in November 1996, dry season/low transmission, and n  26 in May 1997, wet
season/high transmission) (8).
(iii) South America. In Brazil, 29 blood samples were collected from symp-
tomatic individuals visiting the clinic in Porto Velho, Rondônia, in July 1997 and
July to September 1998. In Colombia, 40 samples were collected from symptom-
atic individuals visiting the clinic in El Bagre, Antioquia, in 1998. Details about
the Brazilian and Colombian samples have been provided elsewhere (6). In
Guyana, 33 samples were collected from an all-age population of people with
clinical malaria seeking care at the Georgetown Public Hospital, Georgetown, in
September 1998 (9).
Ethical approvals in these studies (6, 8, 9, 14, 17, 18, 27, 31, 32, 34, 35, 50, 53,
62) were obtained through their respective institutional review boards.
Laboratory-adapted parasite isolates. For MS analyses, genomic DNA prep-
arations from nine P. falciparum laboratory isolates (HB3 [Honduras], 3D7
[unknown origin], Dd2 [Indochina], K1 [Thailand], 7G8 [Brazil], PNG1917
[PNG], PNG1905 [origin not confirmed], ECU1110 [Ecuador], and JAV [Co-
lombia]) were included as references. Parasite strains HB3, 3D7, Dd2, K1, and
7G8 were obtained from MR4, American Type Culture Collection. Strains
PNG1917 and PNG1905 were provided by Alan Cowman, Walter and Eliza Hall
Institute of Medical Research, Melbourne, Australia. Parasite strains HB3, 3D7,
Dd2, K1, 7G8, PNG1917, and PNG1905 were propagated in vitro (55). Genomic
DNA preparations from strains ECU1110 and JAV were provided by Xin-zhuan
Su, Laboratory of Malaria and Vector Research, National Institute of Allergy
and Infectious Diseases (National Institutes of Health [NIH]). DNA was ex-
tracted from cultured P. falciparum parasites by using a QIAamp DNA blood
mini kit (Qiagen, Valencia, CA).
PCR-based analysis of Pfcrt and Pfmdr1 mutations. Except for the samples
from Laos, Pfcrt (codons 72 to 76 [CVMNK, CVIET, SVMNT1, SVMNT2,
CVMNT, and CVMET]) and Pfmdr1 (codons 86 [N/Y], 184 [Y/F], 1034 [S/C],
1042 [N/D], and 1246 [D/Y]) mutations were determined by post-PCR, se-
quence-specific oligonucleotide probe hybridization assays (34). The samples
from Laos were analyzed for Pfcrt (codons 72 to 76) and Pfmdr1 N86Y alleles by
a recently developed PCR-based enzyme-linked immunosorbent assay
method (3).
Analysis of cg2  repeat region and MS loci flanking Pfcrt and Pfmdr1. PCR
amplifications of the cg2  repeat region (chromosome 7) (52), MS loci B5M77,
2E10, 9B12, and 2H4 (flanking Pfcrt; chromosome 7), and MS loci 5-956456,
5-957861, 5-962445, and 5-966096 (flanking Pfmdr1; chromosome 5) were per-
formed with seminested PCR strategies using three primers (Research Genetics,
Huntsville, AL). One of the primers in each nest-2 amplification reaction was 5
labeled with Cy5. All primer sequences, amplification conditions, and methods to
evaluate single- versus multiple-allele infections at each MS locus and to con-
struct allelic haplotypes are provided in Table S1 in the supplemental material
and elsewhere (35). The MS haplotype on chromosome 7 (B5M77_2E10_Pfcrt_
9B12_cg2_2H4) extends 40 kb. The MS haplotype on chromosome 5
(5-956456_5-957861_Pfmdr1_5-962445_5-966096) extends 10 kb. We first an-
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alyzed loci 5-957861 and 5-962445 (extending 5 kb), and if the diversity was
moderate at these loci (locus-by-locus diversity [h], 0.3), then we analyzed loci
5-956456 and 5-966096.
Statistical analysis. The Arlequin 3.0 package (http://cmpg.unibe.ch/software
/arlequin3/) (22) was used to compute the haplotype diversity (H; mean value 
standard error), locus-by-locus diversity (value  standard deviation), mean
number of pairwise differences (MPD), measure of genetic differentiation (Fst),
and linkage disequilibrium (LD) between MS loci. We considered LD between
loci to be significant only after Bonferroni correction for multiple comparisons.
The Arlequin program was also used to perform analyses of molecular variance
(AMOVA) to quantify Pfcrt and Pfmdr1 MS haplotype variation within and
among parasite populations (23). In order to understand the genetic relation-
ships among CQR Pfcrt and Pfmdr1 alleles, median-joining networks based on
the MS haplotypes flanking Pfcrt (four loci [B5M77_2E10_9B12_cg2]; 28 kb)
and Pfmdr1 (two loci [5-957861_5-962445]; 5 kb) were constructed by using the
Network 4.2 program (http://www.fluxus-engineering.com/sharenet.htm) (10).
RESULTS
Pfcrt and Pfmdr1 alleles and flanking MS haplotypes in P.
falciparum laboratory isolates. We analyzed nine P. falciparum
laboratory isolates from diverse geographic locations as refer-
ences and compared their Pfcrt and Pfmdr1 alleles, as well as
the flanking MS haplotypes (see Table S2 in the supplemental
material), with those in the field samples from Asia, Africa,
and South America. Among CQR isolates, different Pfcrt al-
leles occurred on the same MS haplotype (SVMNT1 [isolate
7G8] and SVMNT2 [isolate PNG1905], CVMNT [isolate
ECU1110], and CVMET [isolate JAV]), and the same allele
occurred on different haplotypes (SVMNT1 [isolates 7G8 and
PNG1917]). Interestingly, CQS isolate HB3 and CQR isolates
ECU1110 and JAV shared the same Pfmdr1 allele (NFSDD)
and MS haplotype (see Table S2 in the supplemental material).
For all these P. falciparum laboratory isolates, our results re-
garding Pfcrt alleles and flanking MS loci are concordant with
those of Wootton et al. (65). For isolates HB3, 3D7, Dd2, K1,
7G8, PNG1917, and PNG1905, our results regarding Pfmdr1
alleles are concordant with those of the previous reports (25,
44); to the best of our knowledge, the data regarding Pfmdr1
alleles in isolates ECU1110 and JAV and flanking MS loci (all
isolates) are reported here for the first time.
Overview of Pfcrt and Pfmdr1 alleles in field samples. The
Pfcrt genotypes (codons 72 to 76) are summarized in Table 1.
The CQS CVMNK allele was less prevalent than CQR alleles
(Table 1). Among the CQR alleles, SVMNT1 was the predom-
inant allele in parasites from Asia, and CVIET was the pre-
dominant allele in parasites from Africa. In parasites from
South America, the predominant alleles were SVMNT2 (Bra-
zil), CVMET (Colombia), and SVMNT1, as well as SVMNT2
(Guyana). We observed the CVIET allele in parasites from
India (n  2) and Guyana (n  3), SVMNT1 in parasites from
Brazil (n  2), and SVMNT2 in parasites from Ghana (n  2).
The presence of the SVMNT2 allele in the parasites from
Ghana was confirmed by direct DNA sequencing (34).
The Pfmdr1 genotypes defined by codons 86_184_1034_
1042_1246 are summarized in Table 1 (lower panel). The CQS
NYSND allele was present in parasites from Asia and Africa
but was completely absent in parasites from South America
(Table 1). The CQR YYSND allele was more frequent in
parasites from both Asia (except Laos) and Africa (except
Kenya). We observed a high prevalence of the CQS Pfmdr1
86N alleles in the Laotian (94%) and Kenyan samples (56%),
which also had very high prevalences of the CQR Pfcrt 76T
alleles (91% and 92%, respectively). In the parasites from
South America, we observed that the alleles NFCDY in para-
sites from Brazil and Guyana and NFSDY in parasites from
Colombia were predominant. Two samples from Guyana were
positive for the YYSND allele; these samples were also posi-
tive for the Pfcrt CVIET allele.
MS haplotypes flanking Pfcrt alleles. We observed predom-
inant MS haplotypes (40 kb) associated with CQR Pfcrt alleles
in parasites from Asia (SVMNT1; 3_6_3_5_10 [42%] and 3_6_
3_5_7 [28%]), Africa (CVIET; 3_7_2_4_4 [76%]), and South
America (both SVMNT1 and SVMNT2; 2_3_3_6_7 [92.5%]
and CVMET; 3_2_4_7_10 [96%]) (see Table S3a in the sup-
plemental material). The haplotype associated with the Indian
CVIET allele (3_7_2_11_1; n  2) differed from the haplotype
associated with the most-common Southeast Asian/African
CVIET allele (3_7_2_4_4; seen in isolates Dd2 and K1 [see
TABLE 1. Prevalence of Pfcrt and Pfmdr1 alleles in Asia, Africa, and South America
Gene and allele
Prevalence of allele in country (no. of samples)
PNG (143) Indonesia (34) Laos (29) India (32) Kenya (39) Uganda (30) Ghana (51) Brazil (29) Colombia (40) Guyana (33)
Pfcrta
CVMNK 0.385 0 0c 0 0.051 0 0.294 0 0 0.061
CVIET 0 0 0c 0.063 0.897 0.967 0.412 0 0 0.091
SVMNT1 0.615 1 0.586 0.938 0 0 0 0.069 0 0.364
SVMNT2 0 0 0 0 0 0 0.039 0.931 0 0.333
CVMET 0 0 0 0 0 0 0 0 1 0
Mixed 0 0 0.414 0 0.051 0.033 0.255 0 0 0.152
Pfmdr1b
NYSND 0.168 0 0.923d 0.167 0.361 0.133 0.333 0 0 0
YYSND 0.608 0.92 0.038d 0.733 0.222 0.767 0.533 0 0 0.061
NFCDY 0 0 0 0 0 0 0 1 0 0.939
NFSDY 0 0 0 0 0 0 0 0 1 0
Mixed 0.224 0.08 0.038 0.1 0.417 0.1 0.133 0 0 0
a Codons 72 to 76.
b Codons 86_184_1034_1042_1246.
c Not observed in single infections, but found in mixed infections.
d Genotyping results are available only for N86Y.
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Table S2 in the supplemental material]). We could not amplify
all five MS loci in the parasites from Guyana (CVIET; n  3)
and Ghana (SVMNT2; n  2); hence, complete haplotype
determination for these samples was not possible. The MS
haplotype associated with the Brazilian SVMNT1 allele (2_2_
3_8_7; n  2) differed from the predominant haplotypes ob-
served in the Asian SVMNT1 samples and also from the
SVMNT1 allele-carrying Brazilian laboratory isolate 7G8 (see
Table S2 in the supplemental material).
The CQR Pfcrt allele-associated MS haplotype diversity (40
kb) and MPD for each country are shown in Fig. 1A. Overall,
23 haplotypes were associated with the Pfcrt SVMNT1 allele in
parasites from Asia (H  0.744  0.03, MPD  0.993),
whereas 14 haplotypes were associated with the Pfcrt CVIET
allele in parasites from Africa (H  0.427  0.075, MPD 
0.645) (see Table S3a in the supplemental material). When we
performed locus-by-locus analysis, we found that the locus-
specific diversity at MS 2H4 was much higher in parasites from
Asia (h  0.642  0.027) than in parasites from Africa (h 
0.239  0.067). When this locus was not included in the anal-
ysis, the 4-locus (28 kb) haplotype diversities in Asian (10
haplotypes; H  0.314  0.054, MPD  0.35) and African (10
haplotypes; H  0.337  0.073, MPD  0.406) parasites were
similar (see Table S3b in the supplemental material), indicat-
ing that considerably higher variation at MS 2H4 is responsible
for the overall high haplotype (40 kb) diversity in Asian para-
sites. Compared with the haplotype diversity in parasites from
Asia or Africa, much-lower haplotype (40 kb) diversity was
observed in parasites from South America (Fig. 1A). Overall,
there is much-lower haplotype (40 kb) diversity associated with
CQR alleles (Fig. 1A) than with CQS Pfcrt CVMNK alleles in
parasites from PNG (H  0.995  0.01, MPD  3.903) and
Ghana (H  1.000  0.034, MPD  4.076).
MS haplotypes flanking Pfmdr1 alleles. Among 2-locus (5
kb) haplotypes associated with CQR Pfmdr1 86Y alleles, 5_6
(26%), 11_8 (18%), and 9_5 (12%) in Asian and 8_9 (22%) in
African parasites were the most frequent (see Table S4 in the
supplemental material). Among 4-locus (10 kb) haplotypes
associated with CQR Pfmdr1 86N (with downstream CDY or
SDY) alleles in South American parasites, 9_7_8_2 (Brazil,
100%; Guyana, 92%) and 3_14_8_4 (Colombia, 83%) were the
most frequent.
The CQR Pfmdr1 allele-associated MS haplotype diversity
(5 kb) and MPD for each country are shown in Fig. 1B. Over-
all, the haplotype diversities were high in both Asian (18 hap-
lotypes; H  0.878  0.023, MPD  1.559) and African (19
haplotypes; H  0.936  0.027, MPD  1.541) parasites, and
only two haplotypes were common between these two geo-
graphic regions (see Table S4 in the supplemental material).
Locus-by-locus analysis showed that diversities at both loci
were high (h  0.4 to 0.9). Within Asia, the 2-locus (5 kb)
haplotype diversity was significantly higher in parasites from
PNG and India than in parasites from Indonesia (Fig. 1B).
However, the Indonesian samples exhibited high 4-locus (10
kb) haplotype diversity (H  0.765  0.075, MPD  1.301),
whereas in South American parasites, the 4-locus (10 kb) hap-
lotype diversity was none (Brazil) to low (Colombia and Guy-
ana) (Fig. 1B). CQS Pfmdr1 86N alleles exhibited high 2-locus
(5 kb) haplotype diversity in parasites from PNG (H  0.956 
0.061, MPD  1.622) and Ghana (H  0.978  0.054, MPD 
1.733) but only moderate (H  0.295  0.156, MPD  0.308)
or no (4-locus, 10 kb) diversity in parasites from Laos.
Taken collectively, these results indicate that, unlike Pfcrt
alleles (high genetic diversity for CQS and reduced genetic
diversity for CQR Pfcrt alleles), the genetic diversity is high for
both CQS and CQR Pfmdr1 alleles in parasites from Asia and
Africa. However, similar to CQR Pfcrt alleles, the genetic
diversity is low for CQR Pfmdr1 alleles in parasites from South
America.
LD between Pfcrt and Pfmdr1 loci. In the samples showing
single-allele infections, we observed various frequencies of the
CQR Pfcrt 76T and Pfmdr1 86Y alleles occurring together in
parasites from Asia (67% to 92%) and Africa (20% to 73%)
and of the CQR Pfcrt 76T and Pfmdr1 86N alleles (with down-
stream CDY or SDY) occurring together in parasites from
FIG. 1. (A) Haplotype diversity and MPD of CQR Pfcrt allele-
associated MS haplotypes. All Pfcrt MS haplotypes are 40 kb in
length. The Pfcrt (72 to 76) allele(s) and total number of associated MS
haplotypes (in parentheses) for each region are Asia, SVMNT1 (23);
Africa, CVIET (14); and South America, SVMNT1 and/or SVMNT2
(4) and CVMET (2). The number of unique haplotypes/total number
of haplotypes for each country is PNG, 12/20; Indonesia, 1/6; India,
1/4; Laos, 1/3; Kenya, 1/4; Uganda, 7/8; Ghana, 3/6; Brazil, 1/2; Co-
lombia, 2/2; and Guyana, 1/2 (see Table S3a in the supplemental
material). (B) Haplotype diversity and MPD of CQR Pfmdr1 allele-
associated MS haplotypes. Pfmdr1 MS haplotypes are 5 kb in length
in Asia and Africa and 10 kb in length in South America. The Pfmdr1
(86_184_1034_1042_1246) allele(s) and total number of associated MS
haplotypes (in parentheses) for each region are Asia, YYSND (18);
Africa, YYSND (19); and South America, NFCDY (3) and NFSDY
(2). The number of unique haplotypes/total number of haplotypes for
each country is PNG, 9/10; Indonesia, 1/2; India, 6/6; Uganda, 5/7;
Ghana, 12/12; Brazil, 0/1; Colombia, 1/1; and Guyana, 0/1 (see Table
S4 in the supplemental material). Laos was omitted from the analysis
because all the Laotian samples carried the CQS Pfmdr1 86N allele.
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South America (79% to 100%) (Table 2). Significant associa-
tions were observed between CQR Pfcrt 76T and Pfmdr1 86Y
alleles and between CQS Pfcrt 76K and Pfmdr1 86N alleles in
parasites from PNG (	2 test, 1 df  13.99; P  0.001) and
Ghana (	2 test, 1 df  7.69; P  0.01). This analysis could not
be performed for samples from the other countries because the
CQS Pfcrt 76K allele was absent or was low in prevalence
(Table 1).
We also tested the significance of LD for a complete data set
of Pfcrt and Pfmdr1 MS loci which included samples with
missing data for one or more loci and multiple-allele infec-
tions; the latter were coded as missing data. After correction
for multiple comparisons, significant LD between Pfcrt and
Pfmdr1 MS loci was observed only in parasites from India
(9B12-962445, cg2-957861, and 2H4-962445 [total number of
Pfcrt–Pfmdr1 pairwise comparisons was 10]) and Guyana
(B5M77-957861, 2E10-966096, 2H4-956456, and 2H4-957861
[total number of Pfcrt–Pfmdr1 pairwise comparisons was 12]).
These observations, although limited in their interpretation,
suggest that the associations between Pfcrt and Pfmdr1 genetic
polymorphisms may not correspond to the pattern and extent
of LD between Pfcrt–Pfmdr1 MS loci.
Hierarchical analysis of genetic variation at CQR Pfcrt and
Pfmdr1 loci. The worldwide comparison of genetic variation
between CQR Pfcrt and Pfmdr1 loci using AMOVA shows
substantial differences (Table 3). While the Pfcrt locus has only
25% of the variation within populations, the Pfmdr1 locus
shows 50% of the variation within populations. Further, Pfcrt
has much more between-group variation than between-popu-
lation variation, whereas Pfmdr1 has much more between-
population variation than between-group variation. In fact, the
between-group variation in Pfmdr1 was not significantly differ-
ent from zero. The AMOVA for each separate geographic
region shows that most (Africa and South America) or almost
all (Asia) of the variation in the Pfcrt locus was contained
within populations, with a minimal subdivision among popula-
tions (Africa, 4.72%, and South America, 2.68%) (Table 3).
For the Pfmdr1 locus, although the variation within popula-
tions was considerably higher than the variation among popu-
lations, higher subdivision among populations was noticed for
Asia (37.26%) and Africa (11.47%) than for the Pfcrt locus
(Table 3). Note that the results for parasites from South Amer-
ica depend on whether or not Colombia is included and that
parasites from Brazil and Guyana are quite similar for both the
Pfcrt and Pfmdr1 loci.
Genetic relationships among Pfcrt and Pfmdr1 MS haplo-
types in parasites worldwide. We explored the genetic rela-
tionships among CQR Pfcrt and Pfmdr1 MS haplotypes in
parasites sampled worldwide by constructing networks under
the assumption of a stepwise mutation model for the MS loci.
While many MS loci in P. falciparum parasites seem to be
evolving in a manner consistent with a stepwise mutation
model (7), the mode of MS evolution is uncertain (7, 38). Since
the 2H4 locus exhibited much-higher diversity than other loci
for most of the populations and may not conform to the step-
wise mutation model, as it contains three types of repeat units
TABLE 2. Frequencies of CQR Pfcrt and Pfmdr1 alleles
occurring togethera
Parasite population Frequency (%)
PNG ......................................................................................... 67
Indonesia ................................................................................. 92
India......................................................................................... 88
Kenya....................................................................................... 20b
Uganda .................................................................................... 73
Ghana ...................................................................................... 39c
Brazil........................................................................................100
Colombia .................................................................................100
Guyana .................................................................................... 79
a The Pfcrt 76T and Pfmdr1 86Y alleles occurred together in parasites from
PNG, Indonesia, India, Kenya, Uganda, and Ghana; the Pfcrt 76T and Pfmdr1
86N (with downstream CDY or SDY) alleles occurred together in parasites from
Brazil, Colombia, and Guyana. Note that data from Laos (92.3% CQS Pfmdr1
86N allele; see Table 1) were not included in the analysis.
b 41.7% mixed Pfmdr1 alleles (see Table 1).
c 25.5% mixed Pfcrt and 13.3% mixed Pfmdr1 alleles (see Table 1).
TABLE 3. Distribution of Pfcrt and Pfmdr1 MS haplotype diversity among and within geographic populations by AMOVA
Locus Source of variation
Haplotype diversitye
Worldwide Asian African South American
% Variation P value % Variation P value % Variation P value % Variation P value
Pfcrt Among groupsa 56.97 0.001
Among populationsb 17.63 0.001 0.41 0.307 4.72 0.045 2.68,f 90.94g 0.496,f 0.001g
Within populations 25.39 0.001 99.59 95.28 97.32,f 9.06g
Pfmdr1 Among groupsc 8.07 0.123
Among populationsd 39.51 0.001 37.26 0.001 11.47 0.001 2.14,f 90.39g 0.001f,g
Within populations 52.42 0.001 62.74 88.53 97.86,f 9.61g
a The groups are Asia (SVMNT1), Africa (CVIET), and South America (Brazil and Guyana 
SVMNT1 and/or SVMNT2 and Colombia 
CVMET). All MS
haplotypes are 28 kb. The locus 2H4 was not included in the haplotypes.
b The populations are parasites from PNG, Indonesia, Laos, and India (Asia); Kenya, Uganda, and Ghana (Africa); and Brazil, Colombia and Guyana (South
America).
c The groups are Asia and Africa (YYSND) and South America (Brazil and Guyana 
NFCDY and Colombia 
NFSDY). The length of the MS haplotypes among
groups is 5 kb, irrespective of the population. However, in each geographic region, the length of the MS haplotypes in Asia (PNG, Indonesia, and India) and Africa
(Uganda and Ghana) is 5 kb, while in South America it is 10 kb.
d The populations are parasites from PNG, Indonesia, and India (Asia); Uganda and Ghana (Africa); and Brazil, Colombia, and Guyana (South America). Data for
Laos (CQS Pfmdr1 86N allele) were not included in the AMOVA.
e P, probability of % variation equal to or greater than that observed by chance alone.
f Comparison between Brazil and Guyana.
g Comparison between Brazil and Guyana (combined) and Colombia.
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(T, TA, and TTTA) (52), this locus was omitted from the Pfcrt
network analysis.
Figure 2 displays the evolutionary relationships among all 24
Pfcrt haplotypes (four loci, 28 kb) (see Table S3b in the sup-
plemental material). The median-joining network roughly sep-
arates into three groups, which correspond with geography.
One group consists entirely of South American haplotypes
(H301 [SVMNT1 and/or SVMNT2], H311 [SVMNT1], and
H401 and H411 [both CVMET]). The second group contains
all but two Asian haplotypes, and the third group contains all
African haplotypes plus one Asian (H125 [SVMNT1]) and one
shared Asian/African (H114 [CVIET]) haplotype. In the Asian
group, all SVMNT1-associated haplotypes can be derived from
the most-prevalent haplotype (H001; frequency, 83%) and are
connected to each other mostly by one-step mutations, with the
exception that H028-H031, H031-H030, and H062-H007 ex-
hibit two-step mutations. In the African group, all CVIET-
associated haplotypes can be derived from the most-prevalent
haplotype (H201; frequency, 81%) and are connected to each
other by one-step, two-step, or three-step mutations. H114,
observed in one Ugandan and two Indian samples, seems to
have arisen from the most-prevalent Southeast Asian/African
haplotype (H201; seen in isolates Dd2 and K1 [see Table S2 in
the supplemental material]) by either a multistep mutation
pathway or a recombination event; distinguishing between
these two explanations would require further analysis.
Even though information on Pfcrt (codons 72 to 76) alleles
was not used in constructing the network, there is a consider-
able association between Pfcrt alleles and the groups in the
network, with two exceptions, both involving the SVMNT1
allele: H311 (SVMNT1) is in the network with H301
(SVMNT1 and/or SVMNT2) and H401 (CVMET), and H125
(SVMNT1) is connected to H249 (CVIET). H311 is equidis-
tant (three steps) from both H301 and H401. Although the
origins of SVMNT2, the most-widespread Pfcrt allele in para-
sites from the Amazon region, and SVMNT1, with limited
distribution, are uncertain (61), it is more likely that H311 has
emerged from H301. H125 may reflect homoplasy, as it differs
by one step from H249 and by only three steps from H001
(SVMNT1), which is in the range of variation of other
SVMNT1-associated haplotypes.
Figure 3A displays the evolutionary relationships among all
37 Pfmdr1 haplotypes (two loci, 5 kb) (see Table S4 in the
supplemental material). These haplotypes include those asso-
ciated with the CQS Pfmdr1 86N allele from Laos. In a stark
contrast with the Pfcrt network, the Pfmdr1 network shows
many reticulations, even though there are only two loci, indi-
cating that there have been many parallel changes at these loci.
Moreover, there is no correlation with either geography or
Pfmdr1 alleles; the one Brazilian/Guyanan haplotype (H101,
NFCDY) is quite distant from the one Colombian haplotype
(H201, NFSDY), which is identical to a haplotype observed in
some Ghanaian samples (H033, YYSND; n  3). All haplo-
types from India (YYSND) and Laos (86N) are together with
all of the haplotypes except one from PNG (YYSND), but
haplotypes from Uganda and Ghana also are found in this part of
the network. We also constructed a network for the Pfmdr1 4-lo-
cus (10 kb) haplotype data available for Indonesia (YYSND),
Laos (86N), Brazil (NFCDY), Colombia (NFSDY), and
Guyana (NFCDY). In this network, Brazilian/Guyanan hap-
lotypes grouped with Laotian haplotypes and Colombian
haplotyes grouped with Indonesian haplotypes (Fig. 3B).
The principal outcome of the network analysis is that Pfcrt MS
haplotypes correlate well with geography and CQR Pfcrt alleles,
whereas there is no distinct Pfmdr1 MS haplotype that correlates
with geography and/or CQR Pfmdr1 alleles. Also, these analyses
suggest that CQR Pfmdr1 86Y alleles in parasites from Asia and
Africa had multiple independent origins and have further diver-
sified extensively, much more so than the CQR Pfcrt alleles.
DISCUSSION
In the present study, utilizing samples from diverse regions
where malaria is endemic, two major observations were made
FIG. 2. Median-joining network of CQR Pfcrt allele-associated MS haplotypes. All Pfcrt MS haplotypes are 28 kb in length. H001 to H200,
Asia; H201 to H300, Africa; and H301 to H400, South America (see Table S3b in the supplemental material); the associated Pfcrt allele and
geographic distribution are indicated for each haplotype.
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that are of relevance to public health: (i) in Asian and African
P. falciparum parasite populations, CQR Pfcrt and Pfmdr1 loci
exhibited strikingly different patterns of variation, with CQR
Pfcrt loci exhibiting reduced variation and CQR Pfmdr1 loci
exhibiting high variation, and (ii) in South American P. falcip-
arum parasite populations, both the CQR Pfcrt and Pfmdr1 loci
exhibited considerably lower variation.
Global distribution of CQR Pfcrt and Pfmdr1 alleles. Our
results, together with the results of several previous studies,
suggest that although various CQR Pfcrt and Pfmdr1 alleles
predominate in P. falciparum populations in different geo-
graphic regions and countries, none of these alleles is restricted
to any one particular location (2, 13, 14, 25, 34, 58, 61). Instead,
a variety of alleles can be found in many populations world-
wide. In this study, among the CQR Pfcrt alleles, SVMNT1 in
Asian parasites and CVIET in African parasites were highly
prevalent, with some CVIET and some SVMNT2, respectively.
In South American parasites, the distribution of CQR alleles
varied. In parasites from Brazil, SVMNT2 predominates, with
some SVMNT1. The Colombian parasite population was fixed
for the CVMET allele. The Guyanan parasite population was
quite heterogeneous, with high frequencies of both the
SVMNT1 and SVMNT2 alleles and lower but still appreciable
frequencies of the CVIET allele. Regarding the distribution of
CQR Pfmdr1 alleles, only YYSND in both Asian and African
parasites, NFCDY in Brazilian parasites, and NFSDY in Co-
lombian parasites were observed. In Guyanan parasites, NFCDY
predominates, with some YYSND. Given modern means of
transportation and greater frequency of travel throughout the
world, such a distribution of parasite alleles is not surprising.
On the other hand, certain alleles, such as SVMNT1 in para-
site populations in Asia and South America, may have more
FIG. 3. (A) Median-joining network of Pfmdr1 allele-associated MS haplotypes (5 kb in length). See Table S4 in the supplemental material
for haplotype numbering information. Note that all samples, except those from Laos, carry CQR Pfmdr1 alleles. (B) Median-joining network of
Pfmdr1 allele-associated MS haplotypes (10 kb in length). H001 is 9_7_8_2 (Brazil, n  17, and Guyana, n  12), H002 is 3_14_8_4 (Colombia, n 
11), H003 is 4_14_8_4 (Colombia, n  1), H004 is 15_7_8_2 (Guyana, n  1), H005 is 4_11_5_3 (Indonesia, n  2), H006 is 4_11_8_1 (Indonesia,
n  1), H007 is 5_11_8_1 (Indonesia, n  7), H008 is 5_11_8_2 (Indonesia, n  1), H009 is 5_11_8_3 (Indonesia, n  5), H010 is 7_11_5_3
(Indonesia, n  1), H011 is 7_8_7_4 (Laos, n  11), H012 is 7_8_6_4 (Laos, n  1), and H013 is 7_11_7_4 (Laos, n  1). While samples from
Brazil, Guyana, Colombia, and Indonesia carry CQR Pfmdr1 alleles, Laotian samples carry the CQS Pfmdr1 86N allele.
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than one origin (Fig. 2) (65). Furthermore, as observed with
the Laotian and Kenyan samples in the present study, the
prevalence of sensitive and resistant alleles of both Pfcrt and
Pfmdr1 in the parasite population in any given location could
be heterogeneous due to several local factors: the history of
drug selection pressure (16, 30, 49), parasite population
genetic structure (33), and, possibly, host-intrinsic factors
(42, 54).
Genetic variation at CQR Pfcrt and Pfmdr1 loci in parasites
from Asia and Africa. (i) Dissemination of Pfcrt SVMNT1
allele in parasites from Asia. Despite the fact that CVIET is
the predominant CQR Pfcrt allele in parasites from Southeast
Asia (13, 65), SVMNT1 was the predominant allele in our
Asian samples. This Pfcrt SVMNT1 allele was associated with
an MS haplotype, 3_6_3_5_10, that was observed to be pre-
dominant in all four countries (PNG [21%], Indonesia [64%],
Laos [57%], and India [78%]) (see Table S3a in the supple-
mental material). Therefore, parasites with this or similar hap-
lotypes are likely to be the source of the SVMNT1 founder
allele in Asian parasites. The network analysis (Fig. 2) also
supports the identification of the 4-locus haplotype 3_6_3_5 as
the founder. In a previous study in which we analyzed samples
collected in PNG between 1982 and 1984 (during the early
years of the spread of CQR in PNG), we observed that 97% of
the samples carried the SVMNT1 allele and 83% of those
samples carried the 3_6_3_6_10 haplotype (35). The present
predominant 3_6_3_5_10 haplotype can be derived from the
earlier predominant 3_6_3_6_10 haplotype by just a one-step
mutation. Previously, the SVMNT1 allele-carrying parasites
from PNG were found to closely share the Pfcrt-flanking MS
haplotypes with those from the Philippines and the Solomon
Islands (12). Taking these data together, it appears that the
SVMNT1 allele-carrying parasites, with similar genetic back-
grounds flanking Pfcrt, are widespread in the Asia/Pacific re-
gion.
It is interesting to note that between the two CQR Pfcrt
alleles, CVIET and SVMNT1, that are highly prevalent in
Asian parasites, it is CVIET that moved into Africa and is now
widespread in that continent (13, 65; this study). Recently, the
SVMNT1 allele has been reported in parasites from Iran (58)
and Tanzania (2). This may represent westward movement of
the Asian SVMNT1 allele and may have significance from a
malaria treatment standpoint. The SVMNT1 allele may be
associated with resistance to amodiaquine (48, 63), and there-
fore, the efficacy of artesunate-amodiaquine treatment, which
is becoming increasingly popular in Africa, might be compro-
mised (2).
(ii) Genetic variation of Pfcrt versus Pfmdr1 in Asia and
Africa. In contrast with CQR Pfcrt alleles, the haplotype di-
versities for CQR Pfmdr1 alleles were very high in both Asian
and African parasites. Moreover, in the AMOVA analysis, the
differentiation among both Asian (about 37%) and African
(about 12%) populations for the CQR Pfmdr1 allele-associ-
ated haplotypes was significantly high (Table 3). These obser-
vations suggest that the mechanisms responsible for generating
and/or maintaining genetic variation at Pfcrt and Pfmdr1 loci
are very different. First, differences in the genomic character-
istics of Pfcrt and Pfmdr1 loci may generate different patterns
of genetic variation at these loci; Pfcrt is a single-copy locus
(24), whereas Pfmdr1 can occur as a single- or multiple-copy
locus (56). However, we did not evaluate the Pfmdr1 copy
number in the present study. It is possible that the local re-
combination rate differs between Pfcrt (chromosome 7) and
Pfmdr1 (chromosome 5). The genome average recombination
rate in P. falciparum is 17 kb/centimorgan (51). However, re-
combination is unlikely to be even across the genome, and the
impact of selective events will depend on the local recombina-
tion rate rather than the genome average recombination rate
(5). In addition, it is known that the MS mutation rate in P.
falciparum varies considerably for different types of loci
(1.59  104 [95% confidence interval, 6.98  105 to 3.47 
104]) (6, 7). However, whether the mutation rate varies be-
tween neutral loci and loci under selection, varies from one
chromosome to another, or varies in different allelic lineages,
which may contribute to the extent of hitchhiking around Pfcrt
and Pfmdr1 loci, is not clear.
Second, differences in drug selection history, as well as se-
lection strength, may alter patterns of genetic variation. It is
possible that Pfmdr1 86Y alleles were already present at an
appreciable frequency prior to the spread of resistant Pfcrt 76T
alleles. A recent study conducted in Madagascar observed a
high prevalence (67.5%) of the Pfmdr1 86Y allele, despite the
absence of the Pfcrt 76T allele, in a population supposedly
exposed to CQ for the last 60 years (43). The results of in vitro
tests revealed that all isolates except one were sensitive to CQ,
regardless of the status of Pfmdr1 codon 86 (43).
It is also possible that the strength of CQ selection is differ-
ent for these genes; Pfcrt may be under strong selection pres-
sure, whereas Pfmdr1 may be under weak selection pressure.
Limited studies that have analyzed the prevalence of both the
Pfcrt 76T and Pfmdr1 86Y alleles along with the spread of
CQR in an area over a period of time have found that Pfcrt 76T
alleles spread more rapidly and reached high frequencies faster
than Pfmdr1 86Y alleles (1), suggesting that CQ selection acts
more strongly on Pfcrt than on Pfmdr1. This is likely, consid-
ering the physiologic relevance of PfCRT in the case of CQ
transport and CQR. Both PfCRT and PfMDR1 are integral
membrane proteins, localized to the parasite’s digestive vacu-
ole membrane (59). While PfCRT is considered to be the
primary transporter for CQ, PfMDR1 is considered to be the
primary transporter for mefloquine and a variety of other an-
timalarials (20, 44). Although the precise mechanism of CQR
is still not clear, the efflux of CQ out of the parasite’s digestive
vacuole via an energy-coupled transporter is one of the prom-
ising models of CQR (59). Using allelic-exchange mutant par-
asites, Sanchez et al. (45) showed that stimulated CQ accumu-
lation was associated with Pfcrt alleles CVIET and SVMNT,
but not with Pfmdr1 allele 184F_1034C_1042D_1246Y. They
suggested that PfCRT is, but PfMDR1 is not, directly or indi-
rectly involved in carrier-mediated CQ efflux from resistant
parasites.
Finally, there may indeed be multiple origins of Pfmdr1
polymorphisms (37, 56), in contrast with only a few origins of
CQR Pfcrt alleles (65). If resistance alleles have evolved re-
peatedly on different genetic backgrounds, then the difference
in diversity associated with resistant versus sensitive alleles will
be diminished and the association of individual haplotypes with
resistance mutations will be less clear (5). That is exactly what
we observed regarding Pfmdr1 alleles in parasites from PNG
(for 86Y, H  0.741  0.066, and for 86N, H  0.956  0.06;
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Fst  0.126) and Ghana (for 86Y, H  0.958  0.036, and for
86N, H  0.978  0.054; Fst  0.085), further supporting
multiple origins of CQR Pfmdr1 alleles. Considering that CQ
selection strength may be weaker for Pfmdr1, multiple origins
represent signs of “soft” selection of CQR Pfmdr1 alleles.
Thus, it is possible that reduced variation at Pfcrt is the result
of strong CQ selection together with low local recombination
rates and/or MS mutation rates, whereas high variation at
Pfmdr1 is the result of weak CQ selection together with high
local recombination rates and/or MS mutation rates. Regard-
less of the reasons, the results of the present study show that
there are significant differences between the patterns of ge-
netic variation at the Pfcrt and Pfmdr1 loci in Asian and Afri-
can parasite populations.
Genetic variation at CQR Pfcrt and Pfmdr1 loci in South
America. Compared with the Asian or African parasite popu-
lations, the South American parasite populations were rela-
tively homogeneous for CQR Pfcrt, as well as Pfmdr1, loci.
Although the first reports of CQR came almost simulta-
neously from South America and Southeast Asia (64), the
probable factors and/or mechanisms governing the dynamics of
CQ-driven selective sweeps in South America may have been
substantially different from those in Southeast Asia; a multi-
focal origin of CQR in South America due to high and wide-
spread drug pressure in the form of chloroquinized salt may
have led to the homogenization of CQR-associated genotypes
in a short period of time (64; T. E. Wellems, personal com-
munication). Furthermore, the background level of genetic
variation in the P. falciparum population is quite low in South
America (mean heterozygosities of 12 putatively neutral MS
loci, H  0.3 to 0.4) compared with the levels of variation in
Southeast Asia/Pacific (H  0.51 to 0.65) and Africa (H  0.76
to 0.8) (6), due to small, structured parasite populations with
fewer multiple-clone infections, high levels of inbreeding, and
considerably lower recombination rates (5). Although we did
not estimate the mean number of parasite clones per sample,
MS genotyping revealed that only 1% and 2.9% of all sam-
ples from South America carried multiple alleles at the Pfcrt
and Pfmdr1 loci, respectively (cf. Asia [5% and 5.5%, respec-
tively] and Africa [15% and 18.5%, respectively]). By using one
putatively neutral locus, PfPK2 (chromosome 12), we observed
similar levels of multiple-allele infections in the samples from
South America (3%), Asia (7.6%), and Africa (25.8%). Thus,
it is not surprising to observe that both the CQR Pfcrt and
Pfmdr1 alleles exhibited low diversities in South American
parasites.
Conclusions and implication for malaria treatment. A num-
ber of studies, focused on Pfcrt, have provided convincing
evidence regarding how this gene evolved under CQ selection
pressure (39, 61, 65). So far, two studies, focused on the evo-
lutionary dynamics of Pfmdr1 from two different angles, have
reported different yet complementary outcomes (19, 37).
While the results of the study by Duraisingh et al. (19), using
an intragenic MS locus, indicate a limited number of origins
and a strong selective sweep of Pfmdr1 N86Y alleles in Gam-
bian parasites, the results of the study by Nair et al. (37), using
flanking MS loci, indicate 5 to 15 independent origins and
“soft” selective sweeps of Pfmdr1 amplification events in par-
asites from the Thailand-Burma border. Since we used the
same sets of samples to analyze genetic variation at both the
Pfcrt and Pfmdr1 loci, our results for samples from worldwide
locations provide a unique insight into the evolutionary dy-
namics of these genes. We found that there are marked dif-
ferences between the evolutionary dynamics of Pfcrt and
Pfmdr1 in both Asia and Africa and in the evolutionary dy-
namics of both genes, particularly Pfmdr1, between Asia/Africa
and South America. We observed strong selective sweeps and
a limited number of origins of CQR Pfcrt alleles, a hallmark of
selection at the Pfcrt locus, whereas high levels of variation and
multiple origins of the most-prevalent CQR Pfmdr1 allele
(86Y) were observed in Asia and Africa. In South America, we
observed reduced variation and only a few origins of CQR
Pfcrt, as well as Pfmdr1, alleles. It is most likely that genetic
variation at Pfcrt and Pfmdr1 loci in both Asian and African
parasite populations is generated and/or maintained via sub-
stantially different mechanisms.
CQ is being replaced by newer artemisinin-based combina-
tion drugs, such as artesunate-mefloquine, artemether-lume-
fantrine, and artesunate-amodiaquine, in several countries
where malaria is endemic (http://www.rbm.who.int/). Pfmdr1 is
a major modulator of resistance to these drugs. Understanding
the mechanisms that regulate the genetic variation at Pfmdr1,
separately or in conjunction with Pfcrt, is important, as this
would usefully complement our current efforts to understand
the evolution of the malaria parasite genome under changing
drug pressure. With increased understanding, we might be able
to augment our success in treating this global killer despite our
limited arsenal of drugs.
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SUPPLEMENTAL MATERIAL
TABLE S2. Pfcrt and pfmdr1 alleles and flanking MS loci in P. falciparum laboratory isolates† 
Isolate CQ phenotype pfcrt allelea MS loci flanking pfcrt pfmdr1 alleleb MS loci flanking pfmdr1
B5M77 2E10 9B12 cg2 2H4 5-956456 5-957861 5-962445 5-966096
 (-18 kb)c  (-5 kb)c  (+2 kb)c  (+7 kb)c  (+19 kb)c  (-1.8 kb)d  (-400 bp)d  (+700 bp)d  (+4.3 kb)d
HB3 S CVMNK 4 5 1 1 14 NFSDD 3 14 8 4
3D7 S CVMNK 1 8 3 3 9 NYSND 9 11 8 2
Dd2 R CVIET 3 7 2 4 4 YYSND 4 11 2 4
K1 R CVIET 3 7 2 4 4 YYSND 4 11 2 4
7G8 R SVMNT1 2 3 3 6 7 NFCDY 9 7 8 2
PNG1917 R SVMNT1 3 6 3 5 10 NFSND 11 5 1 1
PNG1905 R SVMNT2 2 3 3 6 7 NFCDY 9 7 8 2
ECU1110 R CVMNT 3 2 4 7 10 NFSDD 3 14 8 4
JAV R CVMET 3 2 4 7 10 NFSDD 3 14 8 4
† MS allele numbers correspond to relative positions of Cy5-labeled PCR amplicons on a 6% denaturing polyacrylamide gel.
a Codons 72–76, b Codons 86_184_1034_1042_1246
c Distance from pfcrt , d Distance from pfmdr1
S = sensitive, R = resistant
SVMNT1 = S(agt)VMNT, SVMNT2 = S(tct)VMNT
SUPPLEMENTAL MATERIAL
TABLE S3a. Distribution and prevalence of pfcrt  MS haplotypes (~40 kb) in various parasite populations† 
Haplotype I.D. pfcrt  (72–76) allele Location (number of samples) pfcrt -flanking microsatellite alleles
B5M77 2E10 9B12 cg2 2H4
 (-18 kb)e  (-5 kb)e  (+2 kb)e  (+7 kb)e  (+19 kb)e
H001 SVMNT1 PNG (31), Indonesia (5) 3 6 3 5 7
H002 SVMNT1 PNG (1), Indonesia (1) 4 6 3 5 7
H005 SVMNT1 PNG (1) 3 6 3 5 13
H006 SVMNT1 PNG (3), Laos (5) 3 6 3 5 11
H007 SVMNT1 PNG (1) 3 6 3 9 7
H011a SVMNT1 PNG (15), Indonesia (16), India (14), Laos (8) 3 6 3 5 10
H015 SVMNT1 PNG (2), Indonesia (1) 3 6 3 5 4
H028 SVMNT1 PNG (1) 3 3 3 5 7
H030 SVMNT1 PNG (1) 3 6 3 6 11
H031 SVMNT1 PNG (1, 1**), Indonesia (1) 3 5 3 5 7
H043 SVMNT1 PNG (1) 3 6 3 5 12
H048 SVMNT1 PNG (1), India (2) 4 6 3 5 10
H053 SVMNT1 PNG (2, 1**) 3 6 3 6 10
H058 SVMNT1 PNG (1), India (1) 3 6 3 4 4
H059 SVMNT1 PNG (2) 3 6 3 5 5
H060 SVMNT1 PNG (2) 3 6 4 5 7
H062 SVMNT1 PNG (1) 3 6 3 7 7
H064 SVMNT1 PNG (1) 3 6 3 6 6
H066 SVMNT1 PNG (1) 3 6 4 5 10
H069 SVMNT1 PNG (1) 3 6 3 6 7
H083 SVMNT1 Indonesia (1) 3 6 3 5 6
H106 SVMNT1 India (1), PNG (1**) 3 6 3 4 10
H114 CVIET India (2) 3 7 2 11 1
H125 SVMNT1 Laos (1) 3 8 2 5 11
H201b CVIET Kenya (22), Uganda (21), Ghana (10)  3 7 2 4 4
H211 CVIET Kenya (1), Ghana (1) 4 7 2 4 4
H216 CVIET Kenya (1) 3 7 2 9 7
H217 CVIET Kenya (1), Ghana (1) 3 7 2 4 7
H230 CVIET Uganda (1) 3 7 2 4 2
H231 CVIET Uganda (1) 3 7 2 3 17
H240 CVIET Uganda (1) 1 7 2 11 17
H245 CVIET Uganda (1) 3 7 2 11 4
H249 CVIET Uganda (1) 3 7 2 5 7
H252 CVIET Uganda (1) 4 9 2 4 4
H253 CVIET Uganda (1) 3 7 2 4 16
H260 CVIET Ghana (3) 3 7 2 7 4
H268 CVIET Ghana (1) 7 7 2 4 4
H270 CVIET Ghana (1) 3 7 2 3 9
H301c SVMNT1/2* Brazil (21), Guyana (16) 2 3 3 6 7
H311 SVMNT1 Brazil (2), 2 2 3 8 7
H330 SVMNT1-2 Guyana (1) 2 3 3 6 14
H401d CVMET Colombia (24) 3 2 4 7 10
H411 CVMET Colombia (1) 3 1 4 7 10
† Samples with single infections only 
a Present in PNG1917 (PNG) isolate (Table S2)
b Present in Dd2 (Indochina) and K1 (Thailand) isolates (Table S2)
c Present in 7G8 (Brazil [SVMNT1]) and PNG1905 (origin not confirmed [SVMNT2]) isolates (Table S2)
d Present in ECU1110 (Ecuador [CVMNT]) and JAV (Colombia [CVMET]) isolates (Table S2)
e Distance from pfcrt
* Brazil = SVMNT2; Guyana = SVMNT1 or SVMNT2
** Samples carry CQS pfcrt- CVMNK allele.
SUPPLEMENTAL MATERIAL
TABLE S3b. Distribution and prevalence of pfcrt  MS haplotypes (~28 kb) in various parasite populations† 
Haplotype I.D. pfcrt  (72–76) allele Location (number of samples) pfcrt -flanking microsatellite alleles
B5M77 2E10 9B12 cg2
 (-18 kb)e  (-5 kb)e  (+2 kb)e  (+7 kb)e
H001a SVMNT1 PNG (55), Indonesia (23), India (14), Laos (13) 3 6 3 5
H002 SVMNT1 PNG (2), Indonesia (1), India (2) 4 6 3 5
H007 SVMNT1 PNG (1) 3 6 3 9
H028 SVMNT1 PNG (1) 3 3 3 5
H030 SVMNT1 PNG (5, 1**) 3 6 3 6
H031 SVMNT1 PNG (1, 1**), Indonesia (1) 3 5 3 5
H058 SVMNT1 PNG (1, 1**), India (2) 3 6 3 4
H060 SVMNT1 PNG (3) 3 6 4 5
H062 SVMNT1 PNG (1) 3 6 3 7
H114 CVIET India (2), Uganda (1) 3 7 2 11
H125 SVMNT1 Laos (1) 3 8 2 5
H201b CVIET Kenya (23), Uganda (23), Ghana (11)  3 7 2 4
H211 CVIET Kenya (1), Ghana (1) 4 7 2 4
H216 CVIET Kenya (1) 3 7 2 9
H231 CVIET Uganda (1), Ghana (1) 3 7 2 3
H240 CVIET Uganda (1) 1 7 2 11
H249 CVIET Uganda (1) 3 7 2 5
H252 CVIET Uganda (1) 4 9 2 4
H260 CVIET Ghana (3) 3 7 2 7
H268 CVIET Ghana (1) 7 7 2 4
H301c SVMNT1/2* Brazil (21), Guyana (17) 2 3 3 6
H311 SVMNT1 Brazil (2) 2 2 3 8
H401d CVMET Colombia (24) 3 2 4 7
H411 CVMET Colombia (1) 3 1 4 7
† Samples with single infections only 
a Present in PNG1917 (PNG) isolate (Table S2)
b Present in Dd2 (Indochina) and K1 (Thailand) isolates (Table S2)
c Present in 7G8 (Brazil [SVMNT1]) and PNG1905 (origin not confirmed [SVMNT2]) isolates (Table S2)
d Present in ECU1110 (Ecuador [CVMNT]) and JAV (Colombia [CVMET]) isolates (Table S2)
e Distance from pfcrt
* Brazil = SVMNT2; Guyana = SVMNT1 or SVMNT2; one sample from Guyana contained SVMNT1-SVMNT2 mixed allele.
** Samples carry CQS pfcrt- CVMNK allele.
SUPPLEMENTAL MATERIAL
TABLE S4. Distribution and prevalence of pfmdr1  MS haplotypes (~5 kb) in various parasite populations † 
Haplotype I.D. pfmdr1 allelea Location (number of samples)     pfmdr1 -flanking microsatellite alleles
5-957861 5-962445
(-400 bp)c (+700 bp)c
H001 YYSND PNG (20) 5 6
H002 YYSND PNG (4) 5 7
H003 YYSND PNG (1) 5 9
H004 YYSND PNG (1) 6 6
H005 YYSND PNG (3) 8 3
H006 YYSND PNG (4) 8 4
H007 YYSND PNG (1), Uganda (2) 8 5
H008 YYSND PNG (4), Laos (1*) 8 6
H009 YYSND PNG (2), Laos (11*) 8 7
H010 YYSND PNG (1) 11 4
H011 YYSND Indonesia (3) 11 5
H012 YYSND Indonesia (14), Uganda (3) 11 8
H013 YYSND India (1) 5 5
H014 YYSND India (2) 7 4
H015 YYSND India (3) 9 4
H016 YYSND India (9) 9 5
H017 YYSND India (1) 9 6
H018 YYSND India (2) 9 7
H019 YYSND Uganda (1) 8 8
H020 YYSND Uganda (8) 8 9
H021 YYSND Uganda (2) 8 10
H022 YYSND Uganda (2) 11 9
H023 YYSND Uganda (2) 11 10
H024 YYSND Ghana (1) 7 5
H025 YYSND Ghana (1) 8 2
H026 YYSND Ghana (1) 10 10
H027 YYSND Ghana (1) 11 3
H028 YYSND Ghana (1) 11 6
H029 YYSND Ghana (1) 12 8
H030 YYSND Ghana (1) 14 5
H031 YYSND Ghana (1) 14 6
H032 YYSND Ghana (2) 14 7
H033b YYSND Ghana (3) 14 8
H034 YYSND Ghana (2) 14 9
H035 YYSND Ghana (1) 14 10
H036 NYSND Laos (1) 11 7
H101 NFCDY Brazil (17), Guyana (13) 7 8
H201b NFSDY Colombia (12) 14 8
† Samples with single infections only
a Codons 86_184_1034_1042_1246
b Same ~5 kb haplotypes, different pfmdr1  alleles
c Distance from pfmdr1
* Samples carry CQS pfmdr1 -86N allele
Note. Due to exhaustion of the Kenyan genomic DNA preparations, pfmdr1 MS analysis could not be performed.   
SUPPLEMENTAL MATERIAL 
 
TABLE S1. Primer sequences, amplification conditions, and the method for genotyping various MS loci  
 
Locus (chromosome) Primer sequences a,b,c Amplification conditions 
cg2 ω repeat region (7) Nest-1:  
Up 5’-TTCTTGAATACTCCTCCCCACACACCTCAC-3’ 
Dn 5’-TCATAAGAATAATAAAATGGATACTGCACAACAAT-3’ 
Nest-2: 
Dn Cy5-5’-GATGAGGAGGATGCCTGGTTTTACTGTCTT-3’ 
94oC 2 min; 94oC 30 sec, 60oC 
30 sec, 72oC 45 sec (25x) 
 
94oC 2 min; 94oC 30 sec, 60oC 
30 sec, 72oC 30 sec (25x)   
B5M77 (7) Nest-1: 
Up 5’-GAAATAATTTCATATACACAC-3’ 
Dn 5’-TATTTCATGTCTCAGTAAAG-3’ 
Nest-2: 
Dn Cy5-5’-TAAAGTCTTTCAATACATATG-3’ 
94oC 2 min; 94oC 30 sec, 54oC 
30 sec, 60oC 30 sec (25x) 
 
Same as for nest-1 
2E10 (7) Nest-1: 
Up 5’-CAAACTTGGATGCAAATGA-3’ 
Dn 5’-AAACACACACATGAACACA-3’ 
Nest-2: 
Up Cy5-5’-TCCAGAGGAATAAAAAATAATA-3’  
94oC 2 min; 94oC 30 sec, 52oC 
30 sec, 60oC 30 sec (25x) 
 
94oC 2 min; 94oC 30 sec, 56oC 
30 sec, 60oC 30 sec (25x) 
9B12 (7) Nest-1: 
Up 5’-GGGTGGAATATATAAGGG-3’ 
Dn 5’-AATGATACAATGGGATTTAC-3’ 
Nest-2: 
Up Cy5-5’-ATATATTCCAGTATGTTCGC-3’ 
94oC 2 min; 94oC 30 sec, 52oC 
30 sec, 60oC 30 sec (25x) 
 
Same as for nest-1 
2H4 (7) Nest-1: 
Up 5’-AAATTGTGGTTCACATAGCA-3’ 
Dn 5’-CGAGAACGCAAAGGTGCC-3’ 
Nest-2: 
Up Cy5-5’-ATCTTTAAGTTCAATCTGGA-3’ 
94oC 2 min; 94oC 30 sec, 52oC 
30 sec, 60oC 30 sec (25x) 
 
Same as for nest-1 
956456 (5) Nest-1: 
Up 5’-TTTTTGTTTGTTCGGAAG-3’ 
Dn 5’- TTACTCAAGGTATTTATAGGATA-3’ 
Nest-2: 
Dn Cy5-5’-CAAGGTATTTATAGGATATTTGA-3’ 
94oC 2 min; 94oC 30 sec, 52oC 
30 sec, 60oC 30 sec (35x) 
 
Same as for nest-1 
957861 (5) Nest-1: 
Up 5’-TTTTTGTCATTGTGTAAATA-3’  
Dn 5’-TTCTGCTCTTTACCCATC-3’ 
Nest-2: 
Dn Cy5-5’-CAACACAAAATCAAATAAAA-3’ 
Same as above 
 
 
Same as above 
962445 (5) Nest-1: 
Up 5’-ACTCTTGTCCGTTATATTGA-3’  
Dn 5’-ATCACACAATTGGTAAACTTT-3’ 
Nest-2: 
Dn Cy5-5’-AAAAAGGAAGAAGGAAAAA-3’ 
Same as above 
 
 
Same as above 
966096 (5) Nest-1: 
Up 5’-AATGTAAATATTTTTAGGGTAGA-3’ 
Dn 5’-CCATATTTTTTCCTTTTGT-3’ 
Nest-2: 
Dn Cy5-5’-TTTTTCCTTTTGTAATATGG-3’ 
Same as above 
 
 
Same as above 
PfPK2 (12)  Nest 1: 
Up 5’-CTTTCATCGATACTACGA-3’ 
Dn 5’-CCTCAGACTGAAATGCAT-3’ 
Nest 2: 
Dn Cy5-5’-AAAGAAGGAACAAGCAGA-3’ 
94oC 2 min ; 94oC 30 sec, 50oC 
30 sec, 72oC 30 sec (25x) 
 
Same as for nest-1 
 
a Chromosome 7 (GenBank accession #AF030694), b Chromosome 5 (GenBank accession #NC_004326), c Chromosome 12 
(GenBank accession #X63648) 
 
All reactions were performed using a Peltier Thermal Cycler, PTC-225 (MJ Research, Watertown, MA) as previously described (34, 
35). Optimization of amplification of MS was performed by varying the MgSO4 concentration between 5.5-8.5 mM in the PCR buffer. 
The PCR products were mixed 3:1 (vol/vol) with denaturing loading dye buffer (formamide 10 ml, bromophenol blue 10 mg, 0.5 M 
EDTA [pH 8.0] 200 ml) and denatured at 95oC for 10 min. The denatured products were then run on a 6% denaturing polyacrylamide 
gel (6.3 M urea/32% formamide) for 3 h in a Gibco BRL sequencing apparatus (model S2, Gibco BRL Life Technologies) at 1900 V. 
The Cy5-labeled amplicons were visualized on the Storm 860 scanner using ImageQuant software v5.2 (Molecular Dynamics, 
Sunnyvale, CA). MS alleles were designated by numbers corresponding to their relative positions on the gel. Multiple-allele infections 
were defined as those in which at least one of the seven or nine loci contained >1 allele. We used “creating a line graph and 
quantitating” function of the ImageQuant software to distinguish single- vs. mixed-allele infections. In this analysis, to be “truly” a 
mixed-allele infection, the graph peak height of the other (or minor) allele must be at least 16.6% of the graph peak height of the 
predominant allele. In our previous (35) as well as present study, we used much more stringent 33% (16.6% × 2) as the cut-off to 
designate other allele, and scored multiple alleles per locus only if minor graph peaks were >33% of the height of the predominant 
graph peak present for each locus. MS genotyping revealed that 6.7%, 8.4%, and 12% of all samples carried multiple alleles at pfcrt, 
pfmdr1, and PfPK2 loci, respectively (Asia, 5%, 5.5%, and 7.6%; Africa, 15%, 18.5%, and 25.8%; South America, <1%, 2.9%, and 
3%). No sample carried more than two alleles at any MS locus. However, we did not estimate the mean number of parasite clones per 
sample. Pfcrt and pfmdr1 allelic haplotypes were constructed using the predominant allele observed at each MS locus.  
